Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy in MS.

Scheibe F, Metz I, Radbruch H, Siebert E, Wolf S, Köhnlein M, Harms L, Meisel A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 10;5(5):e479. doi: 10.1212/NXI.0000000000000479. eCollection 2018 Sep. No abstract available.

PMID:
30027105
2.

Two digital strategies in modern implantology - root-analogue implants and the digital one-abutment/one-time concept.

Schubert O, Beuer F, Güth JF, Nold E, Edelhoff D, Metz I.

Int J Comput Dent. 2018;21(2):115-131.

PMID:
29967904
3.

Drug reaction with eosinophilia and systemic symptoms after daclizumab therapy.

Rauer S, Stork L, Urbach H, Stathi A, Marx A, Süß P, Prinz M, Brück W, Metz I.

Neurology. 2018 Jun 22. pii: 10.1212/WNL.0000000000005854. doi: 10.1212/WNL.0000000000005854. [Epub ahead of print]

PMID:
29934423
4.

Defining distinct features of anti-MOG antibody associated central nervous system demyelination.

Weber MS, Derfuss T, Metz I, Brück W.

Ther Adv Neurol Disord. 2018 Mar 29;11:1756286418762083. doi: 10.1177/1756286418762083. eCollection 2018. Review.

5.

Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain Lesions.

Planas R, Metz I, Martin R, Sospedra M.

Front Immunol. 2018 Mar 19;9:509. doi: 10.3389/fimmu.2018.00509. eCollection 2018.

6.

Rescue therapy with alemtuzumab in B cell/antibody-mediated multiple sclerosis.

Akgün K, Metz I, Kitzler HH, Brück W, Ziemssen T.

Ther Adv Neurol Disord. 2018 Mar 8;11:1756286418759895. doi: 10.1177/1756286418759895. eCollection 2018.

7.

CLIPPERS with longitudinally extensive transverse myelitis: Role of T versus B cells.

Olmes DG, Metz I, Lee DH, Rosenwald A, Doerfler A, Brück W, Linker RA.

J Neurol Sci. 2018 Feb 15;385:96-98. doi: 10.1016/j.jns.2017.12.021. Epub 2017 Dec 18. No abstract available.

PMID:
29406923
8.

Differences in the Reponses to Apheresis Therapy of Patients With 3 Histopathologically Classified Immunopathological Patterns of Multiple Sclerosis.

Stork L, Ellenberger D, Beißbarth T, Friede T, Lucchinetti CF, Brück W, Metz I.

JAMA Neurol. 2018 Apr 1;75(4):428-435. doi: 10.1001/jamaneurol.2017.4842.

PMID:
29404583
9.

Glucose-regulated protein 75 determines ER-mitochondrial coupling and sensitivity to oxidative stress in neuronal cells.

Honrath B, Metz I, Bendridi N, Rieusset J, Culmsee C, Dolga AM.

Cell Death Discov. 2017 Nov 6;3:17076. doi: 10.1038/cddiscovery.2017.76. eCollection 2017.

10.

Flowable composite as a direct restoration technique for primary molars.

Bücher K, Metz I, Pitchika V, Hickel R, Kühnisch J.

Eur J Paediatr Dent. 2017 Sep;18(3):243-246. doi: 10.23804/ejpd.2017.18.03.13. No abstract available.

11.

Relationship between caries experience and demarcated hypomineralised lesions (including MIH) in the permanent dentition of 15-year-olds.

Kühnisch J, Kabary L, Malyk Y, Rothmaier K, Metz I, Hickel R, Heinrich J, Manton D, Standl M.

Clin Oral Investig. 2018 Jun;22(5):2013-2019. doi: 10.1007/s00784-017-2299-4. Epub 2017 Dec 9.

PMID:
29224062
12.

Pattern II and pattern III MS are entities distinct from pattern I MS: evidence from cerebrospinal fluid analysis.

Jarius S, König FB, Metz I, Ruprecht K, Paul F, Brück W, Wildemann B.

J Neuroinflammation. 2017 Aug 29;14(1):171. doi: 10.1186/s12974-017-0929-z.

13.

Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients.

Lalive PH, Kreutzfeldt M, Devergne O, Metz I, Bruck W, Merkler D, Pot C.

J Neuroinflammation. 2017 Jul 24;14(1):144. doi: 10.1186/s12974-017-0919-1.

14.

Association of primary central nervous system vasculitis with the presence of specific human leucocyte antigen gene variant.

Kraemer M, Becker J, Horn PA, Schwitalla JC, Keyvani K, Metz I, Wegner C, Brück W, Schlamann M, Heinemann FM, Berlit P.

Clin Neurol Neurosurg. 2017 Sep;160:137-141. doi: 10.1016/j.clineuro.2017.06.009. Epub 2017 Jun 23.

PMID:
28734234
15.

Differential contribution of immune effector mechanisms to cortical demyelination in multiple sclerosis.

Lagumersindez-Denis N, Wrzos C, Mack M, Winkler A, van der Meer F, Reinert MC, Hollasch H, Flach A, Brühl H, Cullen E, Schlumbohm C, Fuchs E, Linington C, Barrantes-Freer A, Metz I, Wegner C, Liebetanz D, Prinz M, Brück W, Stadelmann C, Nessler S.

Acta Neuropathol. 2017 Jul;134(1):15-34. doi: 10.1007/s00401-017-1706-x. Epub 2017 Apr 6.

16.

Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions.

Popescu BF, Frischer JM, Webb SM, Tham M, Adiele RC, Robinson CA, Fitz-Gibbon PD, Weigand SD, Metz I, Nehzati S, George GN, Pickering IJ, Brück W, Hametner S, Lassmann H, Parisi JE, Yong G, Lucchinetti CF.

Acta Neuropathol. 2017 Jul;134(1):45-64. doi: 10.1007/s00401-017-1696-8. Epub 2017 Mar 22.

17.

ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports.

Körtvélyessy P, Breu M, Pawlitzki M, Metz I, Heinze HJ, Matzke M, Mawrin C, Rommer P, Kovacs GG, Mitter C, Reindl M, Brück W, Wandinger KP, Lassmann H, Höftberger R, Leypoldt F.

Neurol Neuroimmunol Neuroinflamm. 2017 Mar 14;4(3):e335. doi: 10.1212/NXI.0000000000000335. eCollection 2017 May. No abstract available.

18.

Primary central nervous system vasculitis and its mimicking diseases - clinical features, outcome, comorbidities and diagnostic results - A case control study.

Becker J, Horn PA, Keyvani K, Metz I, Wegner C, Brück W, Heinemann FM, Schwitalla JC, Berlit P, Kraemer M.

Clin Neurol Neurosurg. 2017 May;156:48-54. doi: 10.1016/j.clineuro.2017.03.006. Epub 2017 Mar 8.

PMID:
28324788
19.

Diagnostic red flags: steroid-treated malignant CNS lymphoma mimicking autoimmune inflammatory demyelination.

Barrantes-Freer A, Engel AS, Rodríguez-Villagra OA, Winkler A, Bergmann M, Mawrin C, Kuempfel T, Pellkofer H, Metz I, Bleckmann A, Hernández-Durán S, Schippling S, Rushing EJ, Frank S, Glatzel M, Matschke J, Hartmann C, Reifenberger G, Müller W, Schildhaus HU, Brück W, Stadelmann C.

Brain Pathol. 2018 Mar;28(2):225-233. doi: 10.1111/bpa.12496. Epub 2017 Apr 6.

PMID:
28213912
20.

Corrigendum: Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts.

Jenkinson EM, Rodero MP, Kasher PR, Uggenti C, Oojageer A, Goosey LC, Rose Y, Kershaw CJ, Urquhart JE, Williams SG, Bhaskar SS, O'Sullivan J, Baerlocher GM, Haubitz M, Aubert G, Barañano KW, Barnicoat AJ, Battini R, Berger A, Blair EM, Brunstrom-Hernandez JE, Buckard JA, Cassiman DM, Caumes R, Cordelli DM, De Waele LM, Fay AJ, Ferreira P, Fletcher NA, Fryer AE, Goel H, Hemingway CA, Henneke M, Hughes I, Jefferson RJ, Kumar R, Lagae L, Landrieu PG, Lourenço CM, Malpas TJ, Mehta SG, Metz I, Naidu S, Õunap K, Panzer A, Prabhakar P, Quaghebeur G, Schiffmann R, Sherr EH, Sinnathuray KR, Soh C, Stewart HS, Stone J, Van Esch H, Van Mol CE, Vanderver A, Wakeling EL, Whitney A, Pavitt GD, Griffiths-Jones S, Rice GI, Revy P, van der Knaap MS, Livingston JH, O'Keefe RT, Crow YJ.

Nat Genet. 2017 Jan 31;49(2):317. doi: 10.1038/ng0217-317b. No abstract available.

PMID:
28138155
21.

Gingivitis and lifestyle influences on high-sensitivity C-reactive protein and interleukin 6 in adolescents.

Pitchika V, Thiering E, Metz I, Rothmaier K, Willenberg A, Hickel R, Standl M, Kocher T, Heinrich J, Kühnisch J.

J Clin Periodontol. 2017 Apr;44(4):372-381. doi: 10.1111/jcpe.12690. Epub 2017 Feb 11.

PMID:
28036117
22.

Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod.

Sinnecker T, Othman J, Kühl M, Metz I, Niendorf T, Kunkel A, Paul F, Wuerfel J, Faiss J.

Case Rep Neurol Med. 2016;2016:5876798. Epub 2016 Nov 22.

23.

Myelinosome formation represents an early stage of oligodendrocyte damage in multiple sclerosis and its animal model.

Romanelli E, Merkler D, Mezydlo A, Weil MT, Weber MS, Nikić I, Potz S, Meinl E, Matznick FE, Kreutzfeldt M, Ghanem A, Conzelmann KK, Metz I, Brück W, Routh M, Simons M, Bishop D, Misgeld T, Kerschensteiner M.

Nat Commun. 2016 Nov 16;7:13275. doi: 10.1038/ncomms13275.

24.

[Current aspects of senior dentistry].

Grünewald E, Metz I, Edelhoff D.

MMW Fortschr Med. 2016 Nov;158(19):56-60. Review. German. No abstract available.

PMID:
27797033
25.

Comparison of Different Protocols for Performing Adhesive Restorations in Primary Teeth - A Retrospective Clinical Study.

Pitchika V, Metz I, Rothmaier K, Crispin A, Hickel R, Bücher K, Kühnisch J.

J Adhes Dent. 2016;18(5):447-453. doi: 10.3290/j.jad.a36893.

PMID:
27669636
26.

Mutations in SNORD118 cause the cerebral microangiopathy leukoencephalopathy with calcifications and cysts.

Jenkinson EM, Rodero MP, Kasher PR, Uggenti C, Oojageer A, Goosey LC, Rose Y, Kershaw CJ, Urquhart JE, Williams SG, Bhaskar SS, O'Sullivan J, Baerlocher GM, Haubitz M, Aubert G, Barañano KW, Barnicoat AJ, Battini R, Berger A, Blair EM, Brunstrom-Hernandez JE, Buckard JA, Cassiman DM, Caumes R, Cordelli DM, De Waele LM, Fay AJ, Ferreira P, Fletcher NA, Fryer AE, Goel H, Hemingway CA, Henneke M, Hughes I, Jefferson RJ, Kumar R, Lagae L, Landrieu PG, Lourenço CM, Malpas TJ, Mehta SG, Metz I, Naidu S, Õunap K, Panzer A, Prabhakar P, Quaghebeur G, Schiffmann R, Sherr EH, Sinnathuray KR, Soh C, Stewart HS, Stone J, Van Esch H, Van Mol CE, Vanderver A, Wakeling EL, Whitney A, Pavitt GD, Griffiths-Jones S, Rice GI, Revy P, van der Knaap MS, Livingston JH, O'Keefe RT, Crow YJ.

Nat Genet. 2016 Oct;48(10):1185-92. doi: 10.1038/ng.3661. Epub 2016 Aug 29. Erratum in: Nat Genet. 2017 Jan 31;49(2):317.

27.

Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis.

Metz I, Rieckmann P, Kallmann BA, Brück W.

Acta Neuropathol Commun. 2016 Aug 8;4(1):81. doi: 10.1186/s40478-016-0352-1. No abstract available.

28.

Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis.

Spadaro M, Gerdes LA, Krumbholz M, Ertl-Wagner B, Thaler FS, Schuh E, Metz I, Blaschek A, Dick A, Brück W, Hohlfeld R, Meinl E, Kümpfel T.

Neurol Neuroimmunol Neuroinflamm. 2016 Jun 30;3(5):e257. doi: 10.1212/NXI.0000000000000257. eCollection 2016 Oct.

29.

Preventive and invasive treatment in special needs patients: a German retrospective study.

Rothmaier K, Bücher K, Metz I, Pitchika V, Hickel R, Heinrich-Weltzien R, Kühnisch J.

Clin Oral Investig. 2017 May;21(4):1343-1350. doi: 10.1007/s00784-016-1900-6. Epub 2016 Jul 8.

PMID:
27392612
30.

[Integration of foreign nurses in the acute hospital. Giving a face to the enterprise].

Metz I.

Pflege Z. 2016 Jan;69(1):48-51. German. No abstract available.

PMID:
27164817
31.

Mouse model for molybdenum cofactor deficiency type B recapitulates the phenotype observed in molybdenum cofactor deficient patients.

Jakubiczka-Smorag J, Santamaria-Araujo JA, Metz I, Kumar A, Hakroush S, Brueck W, Schwarz G, Burfeind P, Reiss J, Smorag L.

Hum Genet. 2016 Jul;135(7):813-26. doi: 10.1007/s00439-016-1676-4. Epub 2016 May 2.

PMID:
27138983
32.

Immunological and pathological characterization of fatal rebound MS activity following natalizumab withdrawal.

Larochelle C, Metz I, Lécuyer MA, Terouz S, Roger M, Arbour N, Brück W, Prat A.

Mult Scler. 2017 Jan;23(1):72-81. doi: 10.1177/1352458516641775. Epub 2016 Jul 11.

PMID:
27037182
33.

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis.

Metz I, Beißbarth T, Ellenberger D, Pache F, Stork L, Ringelstein M, Aktas O, Jarius S, Wildemann B, Dihazi H, Friede T, Brück W, Ruprecht K, Paul F.

Neurol Neuroimmunol Neuroinflamm. 2016 Feb 2;3(2):e204. doi: 10.1212/NXI.0000000000000204. eCollection 2016 Apr.

34.

Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.

Jarius S, Metz I, König FB, Ruprecht K, Reindl M, Paul F, Brück W, Wildemann B.

Mult Scler. 2016 Oct;22(12):1541-1549. Epub 2016 Feb 11.

PMID:
26869529
35.

6-sulpho LacNAc(+) dendritic cells accumulate in various inflammatory, but not ischaemic conditions of the central nervous system.

Thomas K, Metz I, Tumani H, Brück W, Ziemssen T.

Neuropathol Appl Neurobiol. 2016 Jun;42(4):394-8. doi: 10.1111/nan.12313. No abstract available.

PMID:
26844946
36.

Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions.

Planas R, Metz I, Ortiz Y, Vilarrasa N, Jelčić I, Salinas-Riester G, Heesen C, Brück W, Martin R, Sospedra M.

Ann Clin Transl Neurol. 2015 Sep;2(9):875-93. doi: 10.1002/acn3.218. Epub 2015 Jun 8.

37.

Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.

Frischer JM, Weigand SD, Guo Y, Kale N, Parisi JE, Pirko I, Mandrekar J, Bramow S, Metz I, Brück W, Lassmann H, Lucchinetti CF.

Ann Neurol. 2015 Nov;78(5):710-21. doi: 10.1002/ana.24497. Epub 2015 Aug 24.

38.

Cell type-specific Nrf2 expression in multiple sclerosis lesions.

Licht-Mayer S, Wimmer I, Traffehn S, Metz I, Brück W, Bauer J, Bradl M, Lassmann H.

Acta Neuropathol. 2015 Aug;130(2):263-77. doi: 10.1007/s00401-015-1452-x. Epub 2015 Jun 19.

39.

Glial cells express nuclear nrf2 after fumarate treatment for multiple sclerosis and psoriasis.

Metz I, Traffehn S, Straßburger-Krogias K, Keyvani K, Bergmann M, Nolte K, Weber MS, Bartsch T, Gold R, Brück W.

Neurol Neuroimmunol Neuroinflamm. 2015 Apr 2;2(3):e99. doi: 10.1212/NXI.0000000000000099. eCollection 2015 Jun. No abstract available. Erratum in: Neurol Neuroimmunol Neuroinflamm. 2015 Jun;2(3):e116.

40.

Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasis.

Hoepner R, Faissner S, Klasing A, Schneider R, Metz I, Bellenberg B, Lukas C, Altmeyer P, Gold R, Chan A.

Neurol Neuroimmunol Neuroinflamm. 2015 Mar 12;2(3):e85. doi: 10.1212/NXI.0000000000000085. eCollection 2015 Jun. No abstract available.

41.

Risk factors for secondary caries in direct composite restorations in primary teeth.

Metz I, Rothmaier K, Pitchika V, Crispin A, Hickel R, Garcia-Godoy F, Bücher K, Kühnisch J.

Int J Paediatr Dent. 2015 Nov;25(6):451-61. doi: 10.1111/ipd.12157. Epub 2015 Mar 3.

PMID:
25736557
42.

Natalizumab analogon therapy is effective in a B cell-dependent multiple sclerosis model.

Häusler D, Nessler S, Kruse N, Brück W, Metz I.

Neuropathol Appl Neurobiol. 2015 Oct;41(6):814-31. doi: 10.1111/nan.12220. Epub 2015 May 2.

PMID:
25641089
43.

Extensive acute axonal damage in pediatric multiple sclerosis lesions.

Pfeifenbring S, Bunyan RF, Metz I, Röver C, Huppke P, Gärtner J, Lucchinetti CF, Brück W.

Ann Neurol. 2015 Apr;77(4):655-67. doi: 10.1002/ana.24364. Epub 2015 Feb 26.

44.

High CCR5 expression in natalizumab-associated progressive multifocal leukoencephalopathy immune reconstitution inflammatory syndrome supports treatment with the CCR5 inhibitor maraviroc.

Stork L, Brück W, Bar-Or A, Metz I.

Acta Neuropathol. 2015 Mar;129(3):467-8. doi: 10.1007/s00401-015-1391-6. Epub 2015 Jan 22. No abstract available.

PMID:
25604548
45.

Survival characteristics of composite restorations in primary teeth.

Bücher K, Metz I, Pitchika V, Hickel R, Kühnisch J.

Clin Oral Investig. 2015 Sep;19(7):1653-62. doi: 10.1007/s00784-014-1389-9. Epub 2014 Dec 31.

PMID:
25547072
46.

Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.

Popescu BF, Guo Y, Jentoft ME, Parisi JE, Lennon VA, Pittock SJ, Weinshenker BG, Wingerchuk DM, Giannini C, Metz I, Brück W, Shuster EA, Carter J, Boyd CD, Clardy SL, Cohen BA, Lucchinetti CF.

Neurology. 2015 Jan 13;84(2):148-58. doi: 10.1212/WNL.0000000000001126. Epub 2014 Dec 10.

47.

Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.

Thomas K, Dietze K, Wehner R, Metz I, Tumani H, Schultheiß T, Günther C, Schäkel K, Reichmann H, Brück W, Schmitz M, Ziemssen T.

Neurol Neuroimmunol Neuroinflamm. 2014 Sep 18;1(3):e33. doi: 10.1212/NXI.0000000000000033. eCollection 2014 Oct.

48.

Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning--an ultrahigh-field MR pilot study.

Sinnecker T, Oberwahrenbrock T, Metz I, Zimmermann H, Pfueller CF, Harms L, Ruprecht K, Ramien C, Hahn K, Brück W, Niendorf T, Paul F, Brandt AU, Dörr J, Wuerfel J.

Eur Radiol. 2015 Jan;25(1):122-31. doi: 10.1007/s00330-014-3358-8. Epub 2014 Aug 17.

PMID:
25129119
49.

Pathologic heterogeneity persists in early active multiple sclerosis lesions.

Metz I, Weigand SD, Popescu BF, Frischer JM, Parisi JE, Guo Y, Lassmann H, Brück W, Lucchinetti CF.

Ann Neurol. 2014 May;75(5):728-38. doi: 10.1002/ana.24163. Epub 2014 May 13.

50.

Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome.

Giacomini PS, Rozenberg A, Metz I, Araujo D, Arbour N, Bar-Or A; Maraviroc in Multiple Sclerosis–Associated PML–IRIS (MIMSAPI) Group.

N Engl J Med. 2014 Jan 30;370(5):486-8. doi: 10.1056/NEJMc1304828. No abstract available.

Supplemental Content

Support Center